New Drug Therapy in Peripheral Vascular Disease
Tài liệu tham khảo
Coffman, 1971, Total and capillary fingertip blood flow in Raynaud’s phenomenon, N Engl J Med, 285, 259, 10.1056/NEJM197107292850505
1934, Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis: A multi center trial, JAMA, 251, 2960
Franks, 1982, Topical glyceryl trinitrate as adjunctive treatment in Raynaud’s disease, Lancet, 1, 76, 10.1016/S0140-6736(82)90215-X
Harris, 1977, Aspirin prophylaxis of venous throm boembolism after total hip replacement, N Engl J Med, 297, 1246, 10.1056/NEJM197712082972302
Hull, 1982, Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis, N Engl J Med, 307, 1676, 10.1056/NEJM198212303072704
Hull, 1986, Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis, N Engl J Med, 315, 1109, 10.1056/NEJM198610303151801
Kakkar, 1985, Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis, Am J Surg, 150, 54
Rodeheffer, 1983, Controlled double-blind trial of nifedipine in the treatment of Raynaud’s phenomenon, N Engl J Med, 308, 880, 10.1056/NEJM198304143081507
Salzman, 1975, Management of heparin therapy: Controlled prospective trial, N Engl J Med, 292, 1046, 10.1056/NEJM197505152922002
Sharma, 1980, Effect of thrombolytic therapy on pulmonary capillary blood volume in patients with pulmonary embolism, N Engl J Med, 303, 842, 10.1056/NEJM198010093031502
Smith, 1982, Controlled trial of nifedipine in the treatment of Raynaud’s phenomenon, Lancet, 2, 1299, 10.1016/S0140-6736(82)91508-2